HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heather Burks Selected Research

JDQ443

1/2022Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heather Burks Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 10/2021
1Melanoma (Melanoma, Malignant)
10/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2016
1Prediabetic State (Prediabetes)
01/2016
1Fatty Liver
01/2016
1Overweight
01/2016
1Hyperlipidemias (Hyperlipidemia)
01/2016
1Hypothyroidism
01/2016

Drug/Important Bio-Agent (IBA)

1JDQ443IBA
01/2022
1Small Interfering RNA (siRNA)IBA
10/2021
1LimoninsIBA
10/2021
1Clomiphene (Clomifene)FDA LinkGeneric
01/2016
1Vitamin DFDA LinkGeneric
01/2016